STAT+: Cognito raises $105 million for Alzheimer’s treatment device
Cognito Therapeutics on Thursday said it has raised $105 million as it awaits clinical trial results it hopes will catapult its Alzheimer’s treatment device to Food and Drug Administration clearance. The Series C round was led by Morningside Ventures, IAG Capital Partners, a...
🔗 Read more: https://www.statnews.com/2026/03/05/cognito-fundraise-alzheimers-treatment-device/?utm_campaign=rss
#News #Medicine #Tech #Health #Neuro #Business #Science
Edited
www.statnews.com
STAT+: Cognito raises $105 million for Alzheimer’s treatment device
Cognito Therapeutics on Thursday said it has raised $105 million as it awaits clinical trial results it hopes will catapult its Alzheimer’s treatment device to Food and Drug Administration clearance. The Series C round was led by Morningside Ventures, IAG Capital Partners, and Starbloom Capital,...
Comments
Log in to leave a comment.
No comments yet. Be the first to comment!